161 related articles for article (PubMed ID: 13399154)
1. CORONARY disease, serum-lipids, and thyroid hormones.
Lancet; 1957 Jan; 272(6960):141-2. PubMed ID: 13399154
[No Abstract] [Full Text] [Related]
2. Hydrocortisone and/or desiccated thyroid in physiologic dosage. II. Hypolipemic effects.
MOSES C; JABLONSKI JR; SUNDER JH; GREENMAN JH; DANOWSKI TS
Metabolism; 1962 Jul; 11():653-64. PubMed ID: 14476460
[No Abstract] [Full Text] [Related]
3. Hydrocortisone and/or desiccated thyroid in physiologic dosage. I. Introduction to studies of hypolipemic and other effects including relationships to the aging process.
DANOWSKI TS; MOSES C
Metabolism; 1962 Jul; 11():648-52. PubMed ID: 13883473
[No Abstract] [Full Text] [Related]
4. Usefulness of serum lipids in the prediction and treatment of coronary disease. Part One and Part Two.
ALBRINK MJ
Conn Med; 1960 Jan; 24():27-30. PubMed ID: 13792448
[No Abstract] [Full Text] [Related]
5. [Thrombocytes, lipids and hormones in arteriosclerosis and ischemic heart disease].
Mrochek
Kardiologiia; 1989 Sep; 29(9):102-7. PubMed ID: 2687551
[No Abstract] [Full Text] [Related]
6. [The effect of anapriline on the thyroid function and lipid metabolism in ischemic heart disease in elderly patients].
Gorbachev VV; Pristrom MS
Ter Arkh; 1983; 55(5):53-6. PubMed ID: 6137075
[No Abstract] [Full Text] [Related]
7. Serum-lipids in Israeli communities.
BRUNNER D; LOBL K
Lancet; 1957 Jun; 272(6982):1300-1. PubMed ID: 13440033
[No Abstract] [Full Text] [Related]
8. [The biological syndrome in coronary atherosclerosis].
CLOAREC M
Vie Med; 1961 Nov; 42():1455-8. PubMed ID: 13879972
[No Abstract] [Full Text] [Related]
9. [Studies on the behavior of alimentary chylomicronemia in patients with coronary diseases].
REJOWA A
Pol Arch Med Wewn; 1962; 32():579-84. PubMed ID: 14491369
[No Abstract] [Full Text] [Related]
10. [Effect of anticoagulants on the blood lipid level in patients with coronary atherosclerosis].
MIASNIKOV LA; PIATENKO VI
Sov Med; 1961 Jul; 25():31-5. PubMed ID: 13770122
[No Abstract] [Full Text] [Related]
11. Alimentary lipaemia in men with coronary artery disease and in controls.
BARRITT DW
Br Med J; 1956 Sep; 2(4993):640-4. PubMed ID: 13356039
[No Abstract] [Full Text] [Related]
12. The influence of triiodothyroacetic acid on the circulating lipids and lipoproteins in euthyroid men with coronary disease.
BOYD GS; OLIVER MF
Lancet; 1957 Jan; 272(6960):124-5. PubMed ID: 13399146
[No Abstract] [Full Text] [Related]
13. Idiopathic hyperlipemia associated with coronary atherosclerosis.
MARTT JM; CONNOR WE
AMA Arch Intern Med; 1956 Apr; 97(4):492-6. PubMed ID: 13301082
[No Abstract] [Full Text] [Related]
14. Clinical studies in blood lipid metabolism. VI. Serial serum lipid partitions in patients with chronic coronary artery disease.
GOLDBLOOM AA
Am Pract Dig Treat; 1952 Oct; 3(10):799-803. PubMed ID: 12986162
[No Abstract] [Full Text] [Related]
15. [Clearing factor deficiency in coronary atherosclerosis].
HARTMANN G; STAUB H
Cardiologia (Basel); 1962; 40():245-51. PubMed ID: 13905034
[No Abstract] [Full Text] [Related]
16. The fatty acids of the blood in coronary-artery disease.
JAMES AT; LOVELOCK JE; WEBB J; TROTTER WR
Lancet; 1957 Apr; 272(6971):705-8. PubMed ID: 13417571
[No Abstract] [Full Text] [Related]
17. Cardiac disease and hypothyroidism; complications induced by initial thyroid therapy.
WALLACH EE; LUBASH GD; COHEN BD; RUBIN AL
J Am Med Assoc; 1958 Aug; 167(16):1921-5. PubMed ID: 13563199
[No Abstract] [Full Text] [Related]
18. Prophylaxis of ischaemic heart-disease by thyroid therapy.
BARNES BO
Lancet; 1959 Aug; 2(7095):149-52. PubMed ID: 13796871
[No Abstract] [Full Text] [Related]
19. [Inactive thyroid powder and thyranon].
UYTERLINDE B
Ned Tijdschr Geneeskd; 1962 Mar; 106():427-9. PubMed ID: 13924055
[No Abstract] [Full Text] [Related]
20. Muscular weakness after prolonged ingestion of thyroid.
AITKEN RC; O'CONNOR PJ
Br Med J; 1962 Jul; 2(5297):99-100. PubMed ID: 13859840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
